THE DEFINITIVE GUIDE TO WEGOVY UK

Push release MHRA approves GLP –one receptor agonist semaglutide to reduce chance of significant heart complications in obese or overweight adults Semaglutide is the main weight loss drug accepted in britain as a preventative treatment for people with set up heart problemsWegovy® is a fat loss drug containing the active ingredient, semaglutide.